Here are three things to know.
1. Levocetirizine dihydrochloride is an oral treatment used to relieve symptoms associated with perennial allergic rhinitis in children two years and under.
2. The drug can also be used to treat hives caused by an allergic reaction in adults and children six months and older.
3. Levocetirizine dihydrochloride is the therapeutic equivalent of Sanofi’s allergy drug Xyzal.
More articles on supply chain:
Viewpoint: Why healthcare needs more ‘me too’ drugs
FDA safety warning: Diabetes drug causes higher risk of foot, leg amputations
FDA approves Abon Pharma’s pediatric leukemia drug
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
